MIND's Mission: Advancing Microbiome Science for Healthcare

The human microbiome is one of medicine's final frontiers. Trillions of microorganisms influence immunity, metabolism, mental health, disease susceptibility, and treatment response. Understanding microbiome composition and function is transforming how we diagnose and treat disease.

MIND exists to accelerate microbiome science from laboratory discovery to clinical reality. We conduct research, develop diagnostics, advance therapeutics, and partner with institutions worldwide to unlock the microbiome's potential.

Whether you're an academic researcher, healthcare institution, pharmaceutical company, or public health agency, MIND provides research-grade capabilities addressing your microbiome challenges.

Progenics Labs watermark logo
Turnaround
0-0 Days
Rapid Microbiome Analysis

Fast-track sequencing, bioinformatics profiling, and clinical translation for research samples.

Progenics Labs watermark logo
Stewardship
0-0 Hrs
Rapid AMR Profiling

Swift antimicrobial resistance detection enabling rapid antibiotic optimization and stewardship support.

Progenics Labs watermark logo
Lab Standard
ISO & GLP
Quality & Precision

Backed by PCPNDT compliance, ISO certification, and Good Laboratory Practice (GLP), our laboratory maintains high standards of quality and precision in delivering reliable genetic testing services.

Progenics Labs watermark logo
Led By
0+ Years
Experienced Scientists

Led by Dr. Swapnil and nutiritional counselors offering complete academic interpretation.

Five MIND Service Pillars

Comprehensive microbiome solutions from research to therapeutics

Gut Genomics
01

Comprehensive metagenomic analysis revealing microbiota composition, diversity, pathogenic organisms, and functional capacity.

Whole-genome metagenomic sequencing
Species-level classification
Functional pathway analysis
Dysbiosis detection
Population Interventions
02

Assess microbiome impact within communities and develop population-tailored microbiome health strategies.

Population microbiota profiling
Intervention impact assessment
Community-specific signatures
Public health applications
FMT Services
03

Fecal Microbiota Transplantation services including donor screening, quality control, and clinical protocols.

Donor screening & selection
Microbiota analysis
FMT protocol development
Outcomes monitoring
Rapid AMR Profiling
04

Swift antimicrobial resistance detection enabling rapid antibiotic optimization and stewardship support.

Rapid resistance gene detection
Antibiotic susceptibility profiling
24-48 hour reporting
Stewardship support
Epidemic Response
05

Rapid diagnostic tools for emerging infectious threats supporting swift public health response.

Rapid pathogen identification
Strain characterization
Transmission analysis
Public health integration

MIND Applications Across Healthcare

Real-world partnership examples showing MIND's clinical and research impact

01
Hospital Surgical Outcomes

Optimize surgical outcomes through preoperative microbiome assessment and management.

"Hospital implements gut genomics in pre-surgical risk assessment. Dysbiotic patients receive microbiome optimization. Post-op infection rates decreased 22%."
Improved surgical outcomes
Reduced complications
Competitive differentiation
Implement Hospital Program
02
Pharma Therapeutics

Accelerate microbiota-modifying drug development through comprehensive microbiota analysis.

"Biotech company partners with MIND for Phase 2b microbiota analysis. Robust biomarkers enable efficient Phase 3. FDA approval accelerated."
Accelerated development
Regulatory pathways enabled
Market differentiation
Partner on Therapeutics
03
Public Health Response

Rapid epidemic response through advanced microbiome diagnostics and surveillance.

"Health authority faces unusual outbreak. MIND provides rapid pathogen identification in 48 hours. Public health intervention swift and effective."
Rapid threat identification
Effective outbreak control
Population protection
Establish Public Health Partnership
04
IBD Research

Personalized microbiome management for IBD patients through continuous monitoring.

"GI practice uses gut genomics to monitor IBD microbiome during treatment. Enables optimization of both medical therapy and microbiome interventions."
Better IBD outcomes
Personalized approaches
Research opportunities
Integrate into GI Practice
05
Academic Research

Scale microbiome research through comprehensive analytical services and partnership.

"Researcher partners with MIND for 1,000+ sample analysis. Novel sepsis biomarkers discovered. Publication-quality data delivered."
Large-scale research enabled
Novel discoveries
Career advancement
Collaborate on Research

MIND vs. Traditional Approaches

Side-by-side comparison illustrating MIND's research-grade capabilities

Capability MIND Research-Grade Traditional Microbiology Standard Testing
Comprehensive Analysis Complete metagenomics Culture-dependent (partial) Limited
Speed 5-10 days 2-4 weeks Variable
Pathogen Detection All organisms Culturable only Limited scope
Antibiotic Resistance Genotype-based Phenotype-based Limited
Functional Analysis Yes, pathways Limited No
Research Grade Publication-quality Clinical only Limited data

Why Institutions Partner with MIND

Delivering precision, scalability, and scientific innovation

Competitive Edge

Leading the Frontier of Microbiome Medicine

We combine advanced metagenomic assays, automated bioinformatic workflows, and clinical translation tools to provide elite-grade research capabilities.

100%
Research-Grade Precision

Research Excellence

Built on peer-reviewed methodologies, ISO-certified processes, and publication-quality data to support high-impact research.

Clinical Impact

Proven applications in clinical settings. Enhanced patient outcomes. Measurable improvements supported by evidence.

Innovation Leadership

Cutting-edge methodologies. Patented innovations in microbiome science. Industry-leading technical expertise.

Global Reach

International partnerships. Global collaborations. Public health expertise. A trusted reputation in microbiome science.

Strategic Partnership

Customized solutions designed to support long-term collaboration, shared success, and alignment with your institution's objectives.

Partnership Success Stories

Real-world results delivered to leading health networks and developers

"MIND's microbiota analysis transformed our surgical program. Preoperative microbiome assessment identified high-risk patients, enabling targeted optimization. Post-op complications decreased 22%."
Hospital Surgery Director
22% reduction in surgical complications + Hospital competitive advantage
"MIND's biomarkers enabled FDA approval of our microbiota-modifying therapeutic. Their comprehensive analysis in clinical trials accelerated our regulatory pathway significantly."
Biotech VP Research
Drug approved with MIND biomarkers + Market advantage
"When we faced an unusual outbreak, MIND provided pathogen identification in 48 hours. Their rapid response enabled swift public health intervention protecting our population."
Health Authority Director
Rapid outbreak control + Population health protected

Frequently Asked Questions About MIND

Answers to common questions about research collaboration, turnarounds, and diagnostics

MIND provides comprehensive genomic analysis for research rigor. We analyze complete microbiota composition, functional capacity, and resistance patterns. Clinical labs provide limited pathogen identification. MIND is ideal for research, advanced diagnostics, and therapeutic development.
Yes. MIND provides clinical-grade reports in standard formats compatible with most EHR systems. We work with your IT team for seamless integration of microbiota data into patient records.
5-10 days for comprehensive microbiota analysis. Rapid AMR profiling: 24-48 hours. Epidemic response: expedited timelines. Standard includes metagenomics sequencing, bioinformatic analysis, and expert interpretation.
HIPAA-compliant data management. Encrypted transport and storage. Access controls and audit trails. Samples de-identified when appropriate. Full compliance with all regulatory requirements.
Absolutely. We frequently partner with academic institutions on microbiome research. We provide sample analysis, biostatistical support, and consultation. Many partnerships result in co-authored publications.
Pricing depends on scope and volume. Comprehensive analysis: Rs 25-35K per sample. Volume discounts available. FMT services: Rs 35-50K. Custom pricing for large partnerships. Contact our partnership team for quotes.
Yes. We provide customized training on microbiome science, result interpretation, and clinical applications. Training is tailored to your institution's needs. Ongoing educational support available for partnerships.
Directly. Our Rapid AMR Profiling enables swift identification of antimicrobial resistance. Reports optimized for stewardship decision-making. We integrate with your stewardship algorithms and support program objectives.

Ways to Partner with MIND

Tailored solutions for academic researchers, hospitals, pharmaceutical companies, and public health agencies.

Research Partnership

For: Academic institutions, researchers

Includes: Sample analysis, data analysis,expert consultation

Outcome: Publications, search discoveries, career advancement

Clinical Integration

For: Hospitals, specialty practices

Includes: Diagnostic services, protocol development, training

Outcome: Improved patient outcomes, competitive advantage

Therapeutic Development

For: Pharma, biotech companies

Includes: Preclinical studies, clinical trials, biomarkers

Outcome: Accelerated development, regulatory approval

Public Health Partnership

For: Health agencies, governments

Includes: Surveillance, outbreak response, capacity

Outcome: Population protection, epidemic control

Ready to Partner with MIND?

Whether you're an academic researcher, healthcare institution, pharmaceutical company, or public health agency, MIND offers tailored solutions to address your microbiome research and clinical challenges.

Call MIND Director: +91-8977751239 / +91-8977507781